Results

Cytokinetics Incorporated

04/03/2025 | Press release | Distributed by Public on 04/02/2025 20:37

Effect of Aficamten Treatment for Up to 72 Weeks on Cardiac Structure and Function in Patients with Obstructive Hypertrophic Cardiomyopathy: The SEQUOIA HCM and FOREST HCM CMR[...]

Cytokinetics Incorporated published this content on April 03, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 03, 2025 at 02:38 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]